Dubermatinib

Overview

Dubermatinib (TP-0903) is a potent and selective Axl receptor tyrosine kinase inhibitor with an IC 50 value of 27 nM.

Application

Products | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Pancreatic Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > TAM Receptor | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-12963
• CAS No.: 1341200-45-0
• Molecular Formula: C24H30ClN7O2S
• Molecular Weight: 516.06
• Purity: 99.84%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 1 year , -20°C, 6 months
• Solubility: 10 mg/mL (19.38 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source